slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 28,591-28,620
Pages 10,126
Rows per page 30
Component
28,591-28,620 of 303,780
103
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's product reliability and transparency.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
104
The slide uses highlighted text to emphasize critical quotes from a medical professional.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
105
The slide presents a qualitative case study (KOL #5) to support the thesis of widespread device failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
106
The slide uses direct quotes from two KOLs to highlight perceived contradictions between their public statements and the reality of device performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
107
The slide uses heavy yellow highlighting to emphasize damning statements from anonymous industry experts.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
109
The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
110
The slide uses a direct quote to frame the company's behavior as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
111
The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
112
The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
113
The slide uses aggressive, accusatory language and highlights specific quotes from KOLs to frame Nevro's business practices as unethical and similar to the Insys scandal.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
114
Uses a 'gotcha' interview format to frame the company's business model as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
116
The slide uses a direct quote from a KOL to frame the company's sales tactics as unethical and deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
119
The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
120
Uses testimonials to frame the company as a 'one-tick pony' with a shrinking user base.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
121
Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
122
Uses direct quotes to undermine the company's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
123
The slide uses expert testimony to frame Nevro's business model as unsustainable once 'low-hanging fruit' markets are exhausted.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
124
The slide uses highlighted text to emphasize key claims about market share loss and device failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
125
The slide uses expert testimony to undermine the company's market position and stock performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
126
The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
127
The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
128
The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
129
The slide uses a Q&A format to highlight the discrepancy between appropriate clinical use and the company's sales practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
130
Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
131
Uses direct quotes from the company's own SEC filings to highlight hypocrisy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
132
Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
134
Uses testimonial quotes to undermine company narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
135
Uses authority-citation framework to undermine the company's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
136
Uses highlighted quotes to emphasize negative sentiment from industry experts.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits
137
Uses expert quotes to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory2 hits